source
- HS-10504 Shows Promising Activity in EGFR C797S–Mutant NSCLC After TKI ResistancePhase 1 data show HS-10504 yields encouraging responses and manageable safety in EGFR C797S–mutant NSCLC post TKI therapy.onclive · 2mo ago↗ source
- BioNTech to scale down manufacturing, over 1,800 jobs on the lineBioNTech is making big cuts to its manufacturing footprint. The German company said in its first-quarter earnings release that up to 1,860 manufacturing staff could be impacted by its planned downs…Endpoints · 2mo ago↗ source
- Parsley Health goes in-network nationwideWhen I first heard about Parsley Health close to a decade ago, the startup embodied a few trends I was following closely: primary care startups and cash-pay healthcare. For a ...Endpoints